Filing Flows › Chemed (CHE) › Q2 2025
Chemed (CHE) Q2 2025 earnings results (second quarter 2025)
10-Q filed Jul 31, 2025
Chemed (CHE) reported revenue of $619M for the second quarter 2025 (Q2 2025), +4% from a year earlier and -4% from the quarter before. Operating margin was 11.0%, net earnings $52.5M (8.5% of revenue).
Chemed, Q2 2025: revenue $619M (+4% year over year), operating margin 11.0%, net earnings $52.5M, operating cash flow $139M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $619M | -4% | +4% |
| Operating profit | $68.1M | -28% | -23% |
| Net earnings | $52.5M | -27% | -26% |
| Operating cash flow | $139M | +323% | +79% |
| Free cash flow | $123M | +547% | — |
What changed
Revenue was $618.8M in Q2 2025, up 4% year over year and down 4% from the previous quarter. VITAS was the largest line at 64% of revenue. VITAS added $21.6M year over year (up 6%), 94% of the total change.
Operating profit was $68.1M, a 11.0% margin (down 3.8 points year over year). Operating profit fell $20.0M even though revenue rose $22.9M versus a year earlier, so costs grew faster than sales. Total costs grew 8% against revenue growth of 4%. The fastest-growing cost line was Cost of revenue (+11%). Net earnings were $52.5M, down 26% year over year. The effective tax rate was 26.2%.
Operating cash flow was $138.6M (up 79% year over year), 264% of net earnings. Non-cash charges added back $16.3M of depreciation and amortization. Working capital and other items added $69.9M. Capital expenditures of $15.8M left free cash flow of $122.8M.
Questions
What was Chemed's revenue in the second quarter 2025?
Chemed (CHE) reported revenue of $619M for the second quarter 2025 (Q2 2025), +4% from a year earlier and -4% from the quarter before.
Was Chemed profitable in the second quarter 2025?
Operating profit was $68.1M (11.0% of revenue) and net earnings $52.5M.
Source: Chemed 10-Q on SEC EDGAR.